These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The effect of antiplasma cell sera on the primary immune response. Harris NS; Jagarlamoody SM; McKhann CF; Najarian JS J Immunol; 1972 Apr; 108(4):958-64. PubMed ID: 4554015 [No Abstract] [Full Text] [Related]
5. Prolongation of skin graft survival by donor treatment (donor enhancement). Barkin M; Hambly EJ; Dimitriu D Transplantation; 1972 Jan; 13(1):18-20. PubMed ID: 4550342 [No Abstract] [Full Text] [Related]
6. Cardiac transplantation in mice. II. Effect of continuous immunosuppressive therapy on the survival of H-2-incompatible allografts. Judd KP; Trentin JJ Transplantation; 1971 Mar; 11(3):303-8. PubMed ID: 4934265 [No Abstract] [Full Text] [Related]
7. Immunological enhancement of skin grafts in the mouse. Jeekel JJ; McKenzie IF; Winn HJ J Immunol; 1972 Apr; 108(4):1017-24. PubMed ID: 4112414 [No Abstract] [Full Text] [Related]
8. Connection between the anti-organ and anti-nuclear titres of antilymphocyte sera and their inhibitory effect on skin graft rejection in mice. Fekete B; Petrányi G; Szegedi G; Szabó G Haematologia (Budap); 1971; 5(4):419-23. PubMed ID: 4948255 [No Abstract] [Full Text] [Related]
9. Leukocyte antigens in baboons: a preliminary to tissue typing for organ grafting. Barnes AD; Hawker RJ Transplant Proc; 1972 Mar; 4(1):37-42. PubMed ID: 4622180 [No Abstract] [Full Text] [Related]
10. Antibodies and early human transplant rejection. De Planque BA; Williams GM; Borst-Eilers E; Hume D Transplant Proc; 1971 Mar; 3(1):376-9. PubMed ID: 4106325 [No Abstract] [Full Text] [Related]
11. Bone marrow transplantation incompatibility modified by F 1 graft inocula. Chee CA; Ilbery PL; Motta R Rev Eur Etud Clin Biol; 1972 Jan; 17(1):53-65. PubMed ID: 4402804 [No Abstract] [Full Text] [Related]
12. Soluble transplantation antigens. Further studies of their tolerogenic properties. Law LW; Appella E; Strober S; Wright PW; Fischetti T Transplantation; 1974 Dec; 18(6):487-95. PubMed ID: 4612886 [No Abstract] [Full Text] [Related]
13. Rejection and enhancement in an in vitro model of alloimmunity. Strom TB; Carpenter CB; Phillips SM; Garovoy MR; Merrill JP Transplantation; 1973 Aug; 16(2):103-9. PubMed ID: 4581397 [No Abstract] [Full Text] [Related]
15. Solubilization of lymphocyte and thymocyte antigens by a reversible chemical modification. Eshhar Z; Gafni M; Givol D; Sela M Eur J Immunol; 1971 Nov; 1(5):323-9. PubMed ID: 4945634 [No Abstract] [Full Text] [Related]
16. The effects of heterologous anti-thymocyte sera in mice. I. The use of a graft-vs.-host assay as a measure of homograft reactivity. Mandel MA; Asofsky R J Immunol; 1968 Jun; 100(6):1319-25. PubMed ID: 4880145 [No Abstract] [Full Text] [Related]
17. Transplantation of tooth buds across a multiple non-H-2 barrier. Riviere GR; Sabet TY; Hoffman RL Transplantation; 1971 Oct; 12(4):271-8. PubMed ID: 5113813 [No Abstract] [Full Text] [Related]
19. The Cape Western baboon in organ allotransplantation. Murphy GP; Brede HD; Cohen E; Grace JT Transplant Proc; 1970 Dec; 2(4):546-9. PubMed ID: 5000235 [No Abstract] [Full Text] [Related]
20. A comparative study of the immune reactions of mice to allogenic and xenogenic skin grafts. Novikov DK Sov J Dev Biol; 1974 Jul; 4(4):321-9. PubMed ID: 4610789 [No Abstract] [Full Text] [Related] [Next] [New Search]